Health

Results: 1645-1656 of 10163

Leqembi® Iqlik™ PDUFA date updated to August 24 in the U.S.

Prothena Reports First Quarter 2026 Financial Results and Business Highlights

Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting

PR Newswire associated0

Abu Dhabi Opens Its 'Living Lab' to the World to Accelerate the Future of Health

VARON Reinforces Commitment to Seasonal Respiratory Wellness During Allergy Season Across Europe

PR Newswire associated0

Medit Establishes Global Orthodontic Business Division, Anchored by Strategic Acquisition of Progressive Orthodontics

PR Newswire associated0

MENARINI GROUP: THOMAS CUENI APPOINTED NEW MEMBER OF THE BOARD

SK pharmteco Collaborates with Axle Informatics and the National Institutes of Health to Advance Rare Disease Gene Therapy Programs

PR Newswire associated0

Meiyume Opens Mayfair Innovation Hub, Bringing Beauty Innovation to London

FIRST NICE RECOMMENDED TARGETED TREATMENT OPTION FOR ELIGIBLE PATIENTS LIVING WITH UNRESECTABLE LOCALLY ADVANCED STAGE III EGFR-MUTATED LUNG CANCER

UKHSA update on the hantavirus cruise ship outbreak

Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis